Top 20 Diagnostics Companies of 2025

Top 20 Diagnostics Companies of 2025 Shots: Driven by continuous innovation and enhanced precision, the diagnostic industry is advancing rapidly, transforming the way healthcare is delivered In 2025, the global diagnostic testing market is valued at approximately $207.96B in 2025 and is projected to grow to around $272.9B by 2034, reflecting a CAGR of 3%.…

ByPrince Giri2 days ago

TOP 20

Top 20 Medical Device Companies of 2025

Shots: Driven by continuous innovation, the MedTech sector is evolving rapidly to enhance preventive, diagnostic, and therapeutic capabilities in healthcareIn 2023, the global MedTech market was valued at $668.2B and is projected to reach $989.1B by 2033, growing at a CAGR of approximately 4%. Medtronic led the industry with a revenue of $33.12B, followed…

ByPrince GiriMay 22, 2025

TOP 20

Top 20 Biopharma Deal Terminations of 2023 Based on Total Deal Value

Shots: Sticking to M&A and licensing agreements can be really challenging, especially when dealing with stringent antitrust laws and evolving regulatory challenges. In such adverse scenarios, the rational and right step seems to be nullifying the existing deals.In 2023, the termination of the deal between Janssen and Arrowhead remained the talk of the town…

ByPrince GiriApril 18, 2024

TOP 20

Top 20 Biopharma Companies of 2024

Shots:Driven by innovations and propelled by the pursuit of delivering the best-in-class therapies, 2023 remained a good year for the Biopharma Industry, despite a slight revenue decline, partly due to the conclusion of the COVID-19 pandemicWith a CAGR of 7.8 %, the global biopharma industry is anticipated to register a market size of…

ByPrince GiriApril 11, 2024

TOP 20

Top 20 Radiopharma Companies of 2024 Based on Market Cap

Shots:With diverse applications in diagnostic imaging, theragnostics, and targeted therapy, radiopharmaceuticals are gradually tapping into an ocean of unlimited opportunitiesBy 2030, the radiopharmaceutical market size is expected to grow to $12.18B. In 2023, POINT Biopharma topped the list among radiopharma companies with a market cap of $726.88B followed by Novartis with a market…

ByPrince GiriFebruary 28, 2024

INSIGHTS+

Most Viewed Articles of 2023

2023, remained a busy year for PharmaShots. To keep our readers up to date on the developments in the healthcare sector, PharmaShots worked steadfastly to deliver real-time and real-world updates. Here’s a synopsis of our key reports and most-read news of the year. Top 20 Radiopharma Companies Based on Market Cap Shots: Integrating scintigraphy with…

BySaurabh ChaubeyJanuary 2, 2024

TOP 20

Top 20 Monoclonal Antibodies Based on 2022 Total Revenue

Shots:Monoclonal antibodies are transforming therapeutics through their highly efficient targeting mechanisms. There is a wide range of uses for monoclonal antibodies, including diagnosis, therapy, and researchIn 2021, the monoclonal antibody therapy market size was valued at $178.5B and is envisioned to reach $451.89B by 2028, displaying a CAGR of 14.1%. Humira was the…

ByPrince GiriSeptember 26, 2023

TOP 20

Top 20 Diagnostics Companies Based on 2021 Revenue

The diagnostic companies continued to serve the high demand for diagnostic testing throughout the COVID-19 pandemic in 2021Siemens Healthineers, Roche, GE Healthcare, and Abbott were the top players in the race for the global diagnostic companiesPharmaShots has compiled a list of the top 20 diagnostics Companies based on their 2021 revenue in the…

ByPrince GiriJune 9, 2022

TOP 20

Top 20 Medical Device Companies Based on 2021 Revenue

Despite the severe impact of the Covid-19 pandemic in 2020, the medical device market continued to emerge with patients' more significant needs and emerging diseases In 2021, the medical device markets continued to supply personal protective equipment for the pandemic and new technological developments. Medtronic remains at the top of the ledger with total revenue…

ByPrince GiriMay 12, 2022

TOP 20

Top 20 Life Sciences Deals of 2021 by Total Deal Value

Shots:The life science industry saw high deal activity in 2021 staying in the range of an even busier 2020.Fourth-quarter 2021 set the tone with Recursion’s development and commercialization deal with Roche and Genentech for a total value of $12.7B, followed by Poseida Therapeutics’ development and commercialization deal with Takeda for $3.73B.This article is based on the 2021…

ByPrince GiriFebruary 10, 2022

Top 20 Diagnostics Companies of 2025

Top 20 Medical Device Companies of 2025

Top 20 Biopharma Deal Terminations of 2023 Based on Total Deal Value

Top 20 Biopharma Companies of 2024

Top 20 Radiopharma Companies of 2024 Based on Market Cap

Most Viewed Articles of 2023

Top 20 Monoclonal Antibodies Based on 2022 Total Revenue

Top 20 Diagnostics Companies Based on 2021 Revenue

Top 20 Medical Device Companies Based on 2021 Revenue

Top 20 Life Sciences Deals of 2021 by Total Deal Value

Contact US

OUR INFORMATION

FOLLW US

FOLLW US

Sign Up to Our Newsletter